pgo_multiple_tte {drugdevelopR} | R Documentation |
Probability to go to phase III for multiple endpoints in the time-to-event setting
Description
This function calculates the probability that we go to phase III, i.e. that results of phase II are promising enough to get a successful drug development program. Successful means that at least one endpoint shows a statistically significant positive treatment effect in phase III.
Usage
pgo_multiple_tte(HRgo, n2, hr1, hr2, id1, id2, fixed, rho)
Arguments
HRgo |
threshold value for the go/no-go decision rule; |
n2 |
total sample size for phase II; must be even number |
hr1 |
assumed true treatment effect on HR scale for endpoint OS |
hr2 |
assumed true treatment effect on HR scale for endpoint PFS |
id1 |
amount of information for |
id2 |
amount of information for |
fixed |
choose if true treatment effects are fixed or random |
rho |
correlation between the two endpoints |
Value
The output of the function pgo_multiple_tte()
is the probability to go to phase III.